Literature DB >> 7028911

The vascular bed as the primary target in the destruction of skin grafts by antiserum. I. Resistance of freshly placed xenografts of skin to antiserum.

S V Jooste, R B Colvin, W D Soper, H J Winn.   

Abstract

Rat skin grafted onto immunosuppressed mice is resistant to mouse anti-rat serum during the first 7-10 d after transplantation. It gradually acquires susceptibility, reaching a peak of sensitivity at 14-16 d after grafting. The grafts remain sensitive to antiserum, though at decreasing levels for an additional 3 wk, and grafts that persist beyond that time are resistant to antiserum for as long as they survive. In the study reported here, it is shown that the initial period of resistance to antiserum is due to factors acting locally within the graft and is entirely uninfluenced by the regimen of immunosuppression or the protective dressings that are used. After administration of antiserum, deposits of the injected immunoglobulin and of endogenous C3 are found on the luminal surfaces of graft vessels, although no significant tissue damage is observed. Rat skin that has become highly sensitive to antiserum 14-16 d after transplantation loses that sensitivity if it is regrafted to a new recipient, and then regains it 8-10 d later. Thus, the resistance of freshly grafted skin to antisera is associated with the process of healing into place, a conclusion that is supported by the observation that the intracutaneous administration of antisera to rats causes intense local inflammation and necrosis. The skin is therefore sensitive just before it is removed for grafting, but temporarily loses sensitivity thereafter. Resistance to antiserum during the first 3 or 4 d after transplantation is probably attributable to the fact that at that time grafts are vascularized poorly if at all. The state of resistance extends for several days after vascularization of the graft takes place and is then only gradually lost, a phenomenon that seems to be associated with the resistance of newly formed and regenerating blood vessels to vasoactive substances. This view is in accord with and, indeed, supports the idea that the induction of vascular injury is an essential step in antisera-mediated damage to tissue grafts.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028911      PMCID: PMC2186525          DOI: 10.1084/jem.154.5.1319

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement.

Authors:  P G Gerlag; R A Koene; J F Hagemann; P G Wijdeveld
Journal:  Transplantation       Date:  1975-10       Impact factor: 4.939

2.  Immune mechanisms in homotransplantation. I. The role of serum antibody and complement in the neutralization of lymphoma cells.

Authors:  H J WINN
Journal:  J Immunol       Date:  1960-05       Impact factor: 5.422

3.  Acute destruction by humoral antibody of rat skin grafted to mice.

Authors:  C A Baldamus; I F McKenzie; H J Winn; P S Russell
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

4.  Destruction of rat skin grafts by humoral antibody.

Authors:  S V Jooste; H J Winn; P S Russell
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

5.  Acute destruction of rat skin grafts by alloantisera.

Authors:  S V Jooste; H J Winn
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

6.  Sensitivity of long-standing xenografts of rat hearts to humoral antibodies.

Authors:  J F Burdick; P S Russell; H J Winn
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

7.  The vascular bed as the primary target in the destruction of skin grafts by antiserum. II. Loss of sensitivity to antiserum in long-term xenografts of skin.

Authors:  S V Jooste; R B Colvin; H J Winn
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

8.  Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man.

Authors:  R B Colvin; R A Johnson; M C Mihm; H F Dvorak
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

9.  Acute destruction by humoral antibody of rat skin grafted to mice.

Authors:  H J Winn; C A Baldamus; S V Jooste; P S Russell
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

  9 in total
  12 in total

1.  Microvascular phenomena during pancreatic islet graft rejection.

Authors:  M D Menger; B Wolf; R Höbel; H U Schorlemmer; K Messmer
Journal:  Langenbecks Arch Chir       Date:  1991

2.  The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy.

Authors:  K Csencsits; B E Burrell; G Lu; E J Eichwald; G L Stahl; D K Bishop
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

Review 3.  Immune recognition and rejection of allogeneic skin grafts.

Authors:  Gilles Benichou; Yohei Yamada; Seok-Hyun Yun; Charles Lin; Michael Fray; Georges Tocco
Journal:  Immunotherapy       Date:  2011-06       Impact factor: 4.196

4.  Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.

Authors:  Michael B Auerbach; Naohiko Shimoda; Hiroyuki Amano; Joshua M Rosenblum; Danielle D Kish; Joshua M Farber; Robert L Fairchild
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

Review 5.  Role of complement and NK cells in antibody mediated rejection.

Authors:  Takurin Akiyoshi; Tsutomu Hirohashi; Alessandro Alessandrini; Catherine M Chase; Evan A Farkash; R Neal Smith; Joren C Madsen; Paul S Russell; Robert B Colvin
Journal:  Hum Immunol       Date:  2012-07-28       Impact factor: 2.850

6.  Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts.

Authors:  D P Doody; K S Stenger; H J Winn
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

7.  Haptens can serve as surrogate transplantation antigens in a manner that demonstrates H-2 restriction of graft rejection.

Authors:  J W Streilein; P R Bergstresser
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

8.  Fibronectin is produced by blood vessels in response to injury.

Authors:  R A Clark; J H Quinn; H J Winn; J M Lanigan; P Dellepella; R B Colvin
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

9.  A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection.

Authors:  L LeFrancois; M J Bevan
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

10.  The vascular bed as the primary target in the destruction of skin grafts by antiserum. II. Loss of sensitivity to antiserum in long-term xenografts of skin.

Authors:  S V Jooste; R B Colvin; H J Winn
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.